Age-dependency of galactose elimination capacity in healthy children and children with chronic liver disease

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 2, 2011, Pages 197-200

  Lange, Aksel ^a   Grønbæk, Henning ^a   Vilstrup, Hendrik ^a   Keiding, Susanne ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Children; galactose; liver disease; liver failure; liver function test

Indexed keywords

GALACTOSE;

ADOLESCENT; AGE DETERMINATION; ARTICLE; CAPILLARY BLOOD; CHILD; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG DOSE REDUCTION; DRUG ELIMINATION; FEMALE; FUNCTIONAL ASSESSMENT; GALACTOSE ELIMINATION CAPACITY; HUMAN; INFANT; LIVER FUNCTION TEST; LIVER METABOLISM; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHOOL CHILD;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; GALACTOSE; HUMANS; INFANT; LIVER DISEASES; LIVER FUNCTION TESTS;

EID: 79951752777     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2010.522727     Document Type: Article

References (21)

1. Tygstrup N. Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest Suppl 1966;18:118-25.
2. Marchesini G, Bua V, Brunori A, Bianchi G, Pisi P, Fabbri A, et al. Galactose elimination capacity and liver volume in aging man. Hepatology 1988;8:1079-83.
3. Schnegg M, Lauterburg BH. Quantitative liver function in the elderly assessed by galactose elimination capacity, aminopyrine demethylation and caffeine clearance. J Hepatol 1986;3:164-71. (Pubitemid 17173101)
4. Herold C, Regn S, Ganslmayer M, Ocker M, Hahn EG, Schuppan D. Can quantitative tests of liver function discriminate between different etiologies of liver cirrhosis? Dig Dis Sci 2002;47:2669-73. (Pubitemid 35471604)
5. Herold C, Heinz R, Niedobitek G, Schneider T, Hahn EG, Schuppan D. Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and C. Liver 2001;21:260-65. (Pubitemid 32677382)
6. Herold C, Heinz R, Radespiel-Tröger M, Schneider HT, Schuppan D, Hahn EG. Quantitative testing of liver function in patients with cirrhosis due to chronic hepatitis C to assess disease severity. Liver 2001;21:26-30. (Pubitemid 32112016)
7. Merkel C, Gatta A, Zoli M, Bolognesi M, Angeli P, Iervese T, et al. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score. Dig Dis Sci 1991;36:1197-203.
8. Merkel C, Marchesini G, Fabbri A, Bianco S, Bianchi G, Enzo E, et al. The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death. Hepatology 1996;24:820-3. (Pubitemid 26334280)
9. Jepsen P, Vilstrup H, Ott P, Keiding S, Andersen PK, Tygstrup N. The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study. BMC Gastroenterol 2009;9:50-6.
10. Redaelli CA, Dufour JF, Wagner M, Schilling M, Hsler J, Krähenbhl L, et al. Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg 2002;235:77-85. (Pubitemid 34062402)
11. Salerno F, Borroni G, Moser P, Sangiovanni A, Almasio P, Budillon G, et al. Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the Study of Liver Transplantation. Associazione Italiana per lo Studio del Fegato. J Hepatol 1996;25:474-80. (Pubitemid 26345891)
12. Schmidt LE, Ott P, Tygstrup N. Galactose elimination capacity as a prognostic marker in patients with severe acetaminophen-induced hepatotoxicity: 10 years experience. Clin Gastroenterol Hepatol 2004;2:418-24. (Pubitemid 38561240)
13. Narkewicz MR, Sondheimer HM, Ziegler JW, Otanni Y, Lorts A, Shaffer EM, et al. Hepatic dysfunction following the Fontan procedure. J Pediatr Gastroenterol Nutr 2003;36: 352-7. (Pubitemid 39294740)
14. Narkewicz MR, Smith D, Gregory C, Lear JL, Osberg I, Sokol RJ. Effect of ursodeoxycholic acid therapy on hepatic function in children with intrahepatic cholestatic liver disease. J Pediatr Gastroenterol Nutr 1998;26:49-55. (Pubitemid 28023836)
15. Tygstrup N. Effect of sites of blood sampling in determination of the galactose elimination capacity. Scand J Clin Lab Invest 1977;37:333-8. (Pubitemid 8387586)
16. Kurz G, Wallenfels K D-Galactose, UV test mit Galactosedehydrogenase. In: Bergmeyer HU, editor. Methoden der enzymathischen analyse. Weinheim, Germany: Verlag Chemie; 1970. pp 1241-4.
17. Keiding S, Johansen S, Winkler K, Tønnesen K, Tygstrup N. Michaelis-Menten kinetics of galactose elimination by the isolated perfused pig liver. Am J Physiol 1976;230:1302-13.
18. Donnel GN, Bergren WR, Cleland RS. Galactosemia. Pediatr Clin North Am 1960;7:315-32.
19. Shin-Buehring YS, Beier T, Tan A, Osang M, Schaub J. The activity of galactose-1-phosphate uridyltransferase and galactokinase in human fetal organs. Pediatr Res 1977;11:1045-51. (Pubitemid 8209153)
20. Vink CL. Liver function and age. Clin Chim Acta 1959;4: 674-682.
21. Noda T, Todani T, Watanabe Y, Yamamoto S. Liver volume in children measured by computed tomography. Pediatr Radiol 1997;27:250-2. (Pubitemid 27135415)